Evidence map›Paper›PMID 37999323›Full record

ArticleNanomaterials (Basel, Switzerland)2023

Elaboration of Nanostructured Levan-Based Colloid System as a Biological Alternative with Antimicrobial Activity for Applications in the Management of Pathogenic Microorganisms.

Vitalijs Radenkovs, Anda Valdovska, Daiga Galina, Stefan Cairns, Dmitrijs Jakovlevs, Sergejs Gaidukovs, Ingmars Cinkmanis, Karina Juhnevica-Radenkova

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Vitalijs RadenkovsProcessing and Biochemistry Department, Institute of Horticulture, LV-3701 Dobele, Latvia.ORCID 0000-0001-9443-3525
Anda ValdovskaResearch Laboratory of Biotechnology, Latvia University of Life Sciences and Technologies, LV-3004 Jelgava, Latvia.
Daiga GalinaResearch Laboratory of Biotechnology, Latvia University of Life Sciences and Technologies, LV-3004 Jelgava, Latvia.
Stefan CairnsMalvern Panalytical Ltd., Worcestershire, Malvern WR14 1XZ, UK.
Dmitrijs JakovlevsResearch Laboratory of Biotechnology, Latvia University of Life Sciences and Technologies, LV-3004 Jelgava, Latvia.
Sergejs GaidukovsInstitute of Polymer Materials, Faculty of Materials Science and Applied Chemistry, Riga Technical University, LV-1048 Riga, Latvia.
Ingmars CinkmanisFaculty of Agriculture and Food Technology, Latvia University of Life Sciences and Technologies, LV-3004 Jelgava, Latvia.
Karina Juhnevica-RadenkovaProcessing and Biochemistry Department, Institute of Horticulture, LV-3701 Dobele, Latvia.
Latvia University of Life Sciences and Technologies · LVRiga Technical University · LVWorcestershire Health and Care NHS Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Considering the documented health benefits of bacterial exopolysaccharides (EPSs), specifically of bacterial levan (BL), including its intrinsic antimicrobial activity against certain pathogenic species, the current study concentrated on the development of active pharmaceutical ingredients (APIs) in the form of colloid systems (CoSs) containing silver nanoparticles (AgNPs) employing in-house biosynthesized BL as a reducing and capping agent. The established protocol of fermentation conditions implicating two species of lactic acid bacteria (LAB), i.e.,

Indexed as

biopolymersexopolysaccharideshealinglevanmulti-drug resistancenanoparticleswounds

Identifiers

PMID37999323
PMCPMC10674346
OpenAlexW4388760159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.